Ruyck Soares News Today : Breaking News, Live Updates & Top Stories | Vimarsana

T: +44 20 3709 5700
[email protected] 
About Hyloris Pharmaceuticals SA
Based in Liège, Belgium, Hyloris is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. Hyloris develops proprietary products it believes offer significant advantages compared to currently available alternatives, with the aim to address the underserved medical needs of patients, hospitals, physicians, payors and other stakeholders in the healthcare system.   Hyloris currently has two early commercial-stage products, Sotalol IV for the treatment of atrial fibrillation, commercialised through its partner AltaThera, and Maxigesic® IV, a non-opioid analgesic product for the treatment of pain, developed with the Company s partner, AFT Pharmaceuticals. Additionally, Hyloris has 12 product candidates in various stages of development across the Company s wider portfolio with a focus on intravenous cardio ....

Region Flamande , Gilbert Donders , Chris Welsh , Bart Peeters , Amber Fennell , Marieke Vermeersch , Stijn Van Rompay , Ruyck Soares , Hyloris Pharmaceuticals , Antwerp University Hospital , Global Info Research , Purna Pharmaceuticals , Hyloris Pharmaceuticals Sa Euronext Brussels , University Of Antwerp Belgium , Corporate Communications , University Of Antwerp , Consilium Strategic Communications , Purna Female Healthcare , Euronext Brussels , Domiphen Bromide , Female Healthcare , Van Rompay , Chief Executive Officer , Managing Director , Key Opinion Leader , Chief Executive ,